DSOL — Drug Free Solution Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Drug Free Solution, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2011 May 31st | R2012 May 31st | 2013 May 31st | |
|---|---|---|---|
| Period Length: | 2 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Total Operating Expenses | 0 | 0.548 | 0.756 |
| Operating Profit | -0 | -0.548 | -0.756 |
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0 | -0.626 | -0.756 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0 | -0.626 | -0.756 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0 | -0.626 | -0.756 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | -0 | -0.626 | -0.756 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0 | -0.012 | -0.011 |
| Dividends per Share |